Metsera, Inc. presents four studies on GLP-1 receptor agonist MET-097i at the ADA conference, showcasing clinical and preclinical data. Metsera, Inc., a biopharmaceutical company focused on obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback